Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
Show more...
執行長
Meenu Chhabra
員工
11
國家
US
上市
0 Comments
分享你的想法
FAQ
Kineta 今天的股價是多少?▼
KA 目前價格為 $0.57 USD,過去 24 小時下跌了 -30.69%。在圖表上更密切關注 Kineta 股票的表現。
Kineta 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Kineta 的股票以代號 KA 進行交易。